Palvella Therapeutics Income Statement (2013-2024) | PVLA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Revenue & cost
Revenue 1.37M0.70M0.02M0.22M0.16M0.41M2.14M1.25M1.07M0.79M2.73M1.34M1.85M3.93M18.15M4.15M11.69M8.35M4.91M8.54M5.33M15.13M17.27M13.26M11.25M2.94M1.88M13.00M3.29M4.06M8.44M11.18M3.70M5.37M5.85M2.01M20.09M19.52M1.30M0.05M-0.22M-0.18M
Cost of Revenue 36.00
Operating items
Research & Development 1.22M1.12M0.93M1.52M1.73M2.05M2.94M3.66M4.50M4.62M6.92M5.36M5.40M6.26M5.27M7.94M9.15M11.40M13.00M14.30M13.37M13.21M14.12M12.76M11.33M11.82M10.62M16.56M15.80M18.94M15.36M14.07M11.95M13.59M13.38M13.42M14.33M9.60M-28.55M0.98M1.44M3.18M2.54M
Selling, General & Administrative 274.000.82M2.35M0.93M2.39M1.97M2.24M1.76M1.97M2.37M2.34M2.21M3.99M4.35M2.85M6.39M4.35M4.78M4.75M4.56M4.93M4.19M4.83M4.48M4.36M4.57M4.12M3.67M4.13M4.25M4.13M4.08M4.38M4.08M3.95M3.98M4.02M3.66M6.84M-11.45M0.78M1.47M1.88M1.82M
Other Operating Expenses 0.00M14.89M-14.89M
Operating Expenses 274.000.00M2.04M3.47M1.86M3.92M3.69M4.29M4.70M5.63M6.87M6.96M9.13M9.35M9.74M9.11M11.66M12.29M13.93M16.15M17.56M19.23M17.56M18.05M18.60M17.12M15.90M15.94M14.29M20.69M20.05M23.07M19.44M18.45M16.03M17.54M17.36M17.45M17.99M31.33M-54.90M1.76M2.91M5.06M4.37M
Operating Income -274.00-0.00M-0.67M-2.77M-1.84M-3.70M-3.53M-3.88M-2.57M-4.38M-5.80M-6.18M-6.40M-8.01M-7.89M-5.18M6.49M-8.14M-2.24M-7.80M-12.65M-10.68M-12.23M-2.91M-1.33M-3.86M-4.66M-13.00M-12.41M-5.06M-16.76M-19.01M-11.00M-7.46M-12.33M-12.17M-11.52M-15.51M2.06M-11.81M13.39M-1.76M-2.91M-5.06M-4.37M
EBIT -274.00-0.00M-0.67M-2.77M-1.84M-3.70M-3.53M-3.88M-2.57M-4.38M-5.80M-6.18M-6.40M-8.01M-7.89M-5.18M6.49M-8.14M-2.24M-7.80M-12.65M-10.68M-12.23M-2.91M-1.33M-3.86M-4.66M-13.00M-12.41M-5.06M-16.76M-19.01M-11.00M-7.46M-12.33M-12.17M-11.52M-15.51M2.06M-11.81M13.39M-1.76M-2.91M-5.06M-4.37M
Non-operating items
Interest & Investment Income -0.00M-53.00-0.18M0.15M0.33M0.66M0.50M0.47M0.51M0.45M0.38M0.38M0.32M0.13M0.06M0.01M0.00M0.00M0.00M-0.01M-0.00M0.13M0.24M0.35M0.36M0.49M0.55M0.46M0.24M0.20M0.17M
Other Non Operating Income 583.000.00M148.00769.000.00M-0.00M0.01M0.22M-0.09M-0.02M0.01M0.01M-1.38M-1.73M0.99M-0.90M1.23M1.15M0.33M-0.17M0.02M-0.06M0.18M-0.06M-0.42M-1.34M-1.83M0.88M0.46M0.68M0.38M0.23M0.68M0.72M-0.33M-0.06M-0.16M0.51M0.42M-0.06M-0.27M-0.57M1.67M
Non Operating Income 583.000.00M148.00769.000.00M-0.00M0.01M0.22M-0.09M-0.02M0.01M0.01M-1.38M-1.73M0.99M-0.90M1.23M1.15M0.33M-0.17M0.02M-0.06M0.18M-0.06M-0.42M-1.34M-1.83M0.88M0.46M0.68M0.38M0.23M0.68M0.72M-0.33M-0.06M-0.16M0.51M0.42M0.06M-0.02M0.64M
Net income details
EBT -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.88M-2.74M-4.16M-5.88M-6.20M-6.40M-7.99M-9.27M-6.91M7.63M-8.71M-0.35M-6.15M-11.85M-10.35M-11.76M-2.59M-0.77M-3.54M-4.53M-12.94M-12.40M-5.06M-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-11.17M-15.15M2.55M-11.26M13.84M-2.54M-4.17M-6.78M-3.95M
Tax Provisions -18.00-18.000.04M0.16M0.81M0.15M0.14M-0.15M-0.16M
Profit After Tax -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.92M-2.90M-4.16M-5.88M-6.20M-6.56M-7.99M-10.09M-7.06M7.49M-8.71M-0.20M-6.15M-11.68M-10.35M-11.76M-2.59M-0.80M-3.60M-5.00M-14.30M-14.40M-4.20M-15.50M-16.54M-9.53M-5.10M-10.34M-9.74M-8.12M-13.20M4.00M-10.80M38.69M-2.54M-4.17M-6.78M-3.95M
Income from Continuing Operations -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.92M-2.90M-4.16M-5.88M-6.20M-6.40M-7.99M-10.09M-7.06M7.49M-8.71M-0.20M-6.15M-11.68M-10.35M-11.76M-2.59M-0.77M-3.54M-4.53M-12.94M-12.40M-5.06M-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-11.17M-15.15M2.55M-11.26M13.84M-2.54M-4.17M-6.78M-3.95M
Consolidated Net Income -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.92M-2.90M-4.16M-5.88M-6.20M-6.40M-7.99M-10.09M-7.06M7.49M-8.71M-0.20M-6.15M-11.68M-10.35M-11.76M-2.59M-0.77M-3.54M-4.53M-12.94M-12.40M-5.06M-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-11.17M-15.15M2.55M-11.26M13.84M-2.54M-4.17M-6.78M-3.95M
Income towards Parent Company -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.92M-2.90M-4.16M-5.88M-6.20M-6.40M-7.99M-10.09M-7.06M7.49M-8.71M-0.20M-6.15M-11.68M-10.35M-11.76M-2.59M-0.77M-3.54M-4.53M-12.94M-12.40M-5.06M-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-11.17M-15.15M2.55M-11.26M13.84M-2.54M-4.17M-6.78M-3.95M
Preferred Dividend Payments 0.19M0.19M0.19M-0.58M
Net Income towards Common Stockholders -274.00-0.00M-0.78M-2.88M-2.02M-3.70M-3.53M-3.92M-2.90M-4.16M-5.88M-6.20M-6.40M-7.99M-10.09M-7.06M7.49M-8.71M-0.20M-6.15M-11.68M-10.35M-11.76M-2.59M-0.77M-3.54M-4.53M-12.94M-12.40M-5.06M-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-11.17M-15.15M2.55M-11.26M13.84M-2.73M-4.37M-6.97M-3.37M
Additional items
EPS (Basic) -0.07-0.24-0.17-0.13-0.12-0.10-0.07-0.10-0.14-0.14-0.16-0.19-0.23-0.160.18-0.17-0.30-0.11-0.21-0.20-0.24-0.05-0.06-0.07-0.09-0.26-0.26-0.07-0.25-0.24-0.13-0.07-0.14-0.13-0.11-14.153.63-8.7020.52-1.54-2.47-3.940.12
EPS (Weighted Average and Diluted) -0.07-0.26-0.26-0.07-0.25-0.24-0.13-0.07-0.14-12.70-8.7020.50-1.54-2.47-3.940.12
Shares Outstanding (Weighted Average) 0.37M0.37M0.49M0.50M0.50M0.50M0.50M0.54M0.54M0.54M0.54M0.55M0.56M0.67M0.67M0.68M0.68M0.61M0.61M0.62M0.69M0.69M0.65M0.65M0.70M0.75M0.79M0.83M0.90M0.93M0.93M0.93M0.93M0.93M1.03M1.24M1.24M1.24M1.32M1.32M1.32M
Shares Outstanding (Diluted Average) 53.79M54.34M54.48M56.30M61.91M67.73M64.55M73.71M74.12M1.10M1.24M1.77M1.77M1.77M
EBITDA -274.00-0.00M-0.67M-2.77M-1.84M-3.70M-3.53M-3.88M-2.57M-4.38M-5.80M-6.18M-6.40M-7.94M-10.73M-7.45M5.28M-9.99M3.20M-6.63M-11.61M-9.42M-12.41M-0.58M-2.07M-2.83M-4.79M-14.00M-13.91M-3.68M-15.46M-16.15M-9.32M-4.98M-10.67M-9.84M-8.88M-13.36M4.26M-10.95M37.96M-2.73M-4.37M-6.97M-3.37M
Interest Expenses 0.11M0.11M0.00M53.000.22M0.18M
Tax Rate 0.00%0.00%1.89%42.17%1.38%